-
1 Comment
Shanghai Xuerong Biotechnology Co., Ltd is currently in a long term downtrend where the price is trading 28.3% below its 200 day moving average.
From a valuation standpoint, the stock is 70.5% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 2.0.
Shanghai Xuerong Biotechnology Co., Ltd's total revenue rose by 29.9% to $568M since the same quarter in the previous year.
Its net income has increased by 1186.2% to $61M since the same quarter in the previous year.
Finally, its free cash flow grew by 566.5% to $27M since the same quarter in the previous year.
Based on the above factors, Shanghai Xuerong Biotechnology Co., Ltd gets an overall score of 4/5.
Exchange | SHE |
---|---|
CurrencyCode | CNY |
Sector | Consumer Defensive |
Industry | Farm Products |
ISIN | CNE100002706 |
Market Cap | 4B |
---|---|
Beta | 0.17 |
PE Ratio | None |
Target Price | 10.7 |
Dividend Yield | 0.0% |
Shanghai Xuerong Biotechnology Co., Ltd., together with its subsidiaries, engages in the research and development, industrial planting, and sale of fresh edible mushrooms in the People's Republic of China. It offers enoki, shiitake, king oyster, and shiitake mushrooms, as well as deer Flammulina velutipes. The company was formerly known as Shanghai Gaorong Food Co., Ltd. Shanghai Xuerong Biotechnology Co., Ltd. was founded in 1997 and is headquartered in Shanghai, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300511.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024